Rashed Dewan
Director of Finance/CFO at PROFOUND MEDICAL CORP.
Net worth: 175 015 $ as of 2024-05-30
Rashed Dewan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PROFOUND MEDICAL CORP. | Director of Finance/CFO | 2022-03-02 | - |
| Comptroller/Controller/Auditor | 2021-05-18 | 2022-03-02 | |
| Human Resources Officer | - | 2022-03-02 | |
| Corporate Officer/Principal | 2018-05-02 | 2021-05-18 |
Career history of Rashed Dewan
Former positions of Rashed Dewan
| Companies | Position | Start | End |
|---|---|---|---|
Profound Medical, Inc.
 Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada. | Comptroller/Controller/Auditor | 2015-07-05 | - |
Training of Rashed Dewan
| University of Southern California | Undergraduate Degree |
Statistics
International
| Canada | 3 |
| United States | 2 |
Operational
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Human Resources Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PROFOUND MEDICAL CORP. | Health Technology |
| Private companies | 1 |
|---|---|
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Rashed Dewan
- Experience
